Nkx-2.5 Regulates MDR1 Expression via Its Upstream Promoter in Breast Cancer Cells.
Jung-Suk LimGyu Yeon JungSeung-Yoon ParkPublished in: Journal of Korean medical science (2019)
The results in the present study show Nkx-2.5 is a positive regulator for the transactivation of MDR1 USP in MCF7 breast cancer cells. Our findings will help elucidate the regulatory mechanism responsible for the multidrug resistant cancer phenotype.